Subscribe to Newsletter

Advanced Medicine

Discovery & Development Drug Discovery

Enhancing CRISPR-Cas9

| Stephanie Vine | 3 min read

Is safeguard sgRNA the key to reducing the off-target effects of gene editing, while increasing its potential applications?

Manufacture Advanced Medicine

The Synthetic Construct

| Jason Lehmann, Jyotsna Venugopal | 4 min read

Why automated synthetic biology solutions can pave the way forward for both TCR-T and CAR-T research.

Discovery & Development Drug Discovery

Genetic Science and Sudden Infant Death Syndrome

| Stephanie Vine | 4 min read

The case of Kathleen Folbigg shows how far the field has come, but there are still no medical interventions for sudden infant death syndrome.

Discovery & Development Drug Delivery

Revenge of the ADCs

| Stephanie Vine | 15 min read

Are antibody drug conjugates (ADCs) the breakthrough in cancer treatment? Experts share insights on recent advancements

Discovery & Development Drug Discovery

Power List Perspectives: Industry Breakthroughs

| Jamie Irvine | 3 min read

Pharma experts discuss the most exciting industry breakthroughs in recent years

Manufacture Advanced Medicine

Scaling Gene Therapy Challenges – Together

| Catherine Buchere, Kathrin Teschner | 7 min read

Understanding AAV production and characterization processes – and establishing strategies for success.

Discovery & Development Drug Discovery

Lung Cancer Collaboration

| Jamie Irvine | 2 min read

The Lung Cancer Research Foundation has partnered with Daiichi Sankyo and AstraZeneca to offer grants for research exploring ADCs against lung cancer

Discovery & Development Drug Delivery

Power List Perspectives: Challenges Facing Cell and Gene Therapy

| Jamie Irvine

Leading pharma industry experts discuss the most pertinent challenges facing cell and gene therapy

Discovery & Development Formulation

T Cell Bright Spark

| 3 min read

An insight into the research fuelling developments for universal cancer immunotherapies

Manufacture Advanced Medicine

Roundtable Discussion: Priorities for the Cell and Gene Field

| Stephanie Vine

Three experts give their views on the state of play in cell and gene manufacturing, and the challenges that lie ahead

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register